Pychemedics begins to market hair testing commercially

0

Pychemedics begins to market hair testing commercially. Pychemedics Board of Directors includes hair-testing pioneer Werner Baumgartner [Chairman, owing 7.2 % of stock in the company] as well as H. Wayne Huizenga [lead investor, owning 12.9 % of stock in Pychemedics and chairman and CEO of Blockbuster Entertainment Corp.], A. Clinton Allen III [a Blockbuster director and Pychemedics vice chairman and director, owing 9.6 % of Pychemedics stock], Donald F. Flynn [a director of both Blockbuster and Pychemedics, owing 12.2 % stock in Pychemedics] and John J. Melk [also a director of both Blockbuster and Pychemedics, owing 12.2 % stock in Pychemedics]. The Blockbuster Directors own a total of 47% in Pychemedics.